ClinicalTrials.gg
Sign In

Drug

Actinium-225 clinical trials

studies test it
12
open now
9
in phase 3
1
first study started
2019

Keep track of what changes. Save the Actinium-225 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

[225Ac]Ac-AKY-2519 (therapeutic)
2
[225Ac]Ac-DOTATATE
2

Studies by the year they started

12 studies that test it; most in 2026 (7)

Studies that test Actinium-225, by start year
YearStudies
20191
20242
20252
20267

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
2
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Prostatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
1
Colorectal Neoplasms
1
Triple Negative Breast Neoplasms
1
Breast Neoplasms
1
Uveal Melanoma
1
Endometrial Neoplasms
1

Who runs them

Industry 9 · Other 3

Aktis Oncology, Inc. (3) · Alpha-9 Oncology USA Inc. (2) · Peking University Cancer Hospital & Institute (2) · Eli Lilly and Company (1) · AstraZeneca (1) · Full-Life Technologies UK Limited (1) · University College, London (1) · Fusion Pharmaceuticals Inc. (1)

Often tested with

Tested in the same studies.

Lutetium-177 (1)

Studies

Open first, then newest update. How each study uses Actinium-225 is read from its arms, and is right about nine times in ten.

Testing it · 12